UnicoCell Biomed Company Description

UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

It develops ELIXCYTE, which is in Phase 2 clinical trials for the treatment of osteoarthritis and chronic kidney disease.

The company offers UnicoVial, a cryotube and drug container for cell therapy products, as well as provides testing services.

UnicoCell Biomed Co., Ltd. is based in Taipei, Taiwan.

UnicoCell Biomed Co., Ltd.

Country	Taiwan
Industry	Biotechnology
Sector	Healthcare
CEO	Yi-Pei Hung

Contact Details

Address: No. 13-20, Minquan East Road Taipei, 11494 Taiwan
Phone	886 2 2792 2699
Website	unicocell.com

Stock Details

Ticker Symbol	6794
Exchange	Taiwan Stock Exchange
Fiscal Year	January - December
Reporting Currency	TWD
SIC Code	2836

Key Executives

Name	Position
Yi-Pei Hung	Chief Executive Officer